FDD Leaders Handbook
FDD Leaders Handbook featured the leaders in formulation development and drug delivery who are helming India’s journey to become…
Author
Lynparza approved by US FDA
Lynparza is the first and only PARP inhibitor approved for use beyond ovarian cancer
Lupin forays into OTC segment
Launches Softovac under the umbrella of Lupin Life Consumer Healthcare
Glenmark initiates Phase IIb dose range finding study
The study will evaluate safety and efficacy of GRC 27864 in patients with moderate osteoarthritic pain
Intas acquires generics business of Actavis in UK, Ireland
This acquisition is set to more than double Intas' pan-European operations, with pro-forma revenues exceeding $500 million
Livongo and Lilly collaborate on real-world diabetes research
Companies join forces to advance predictive and prescriptive recommendations for people with diabetes
Eisai set-ups new OSD production facility in China
Operations are expected to commence in the second half of fiscal 2018
EU approves AstraZeneca’s Fasenra
Fasenra is comapany's first respiratory biologic medicine for severe eosinophilic asthma
Biogen and Eisai promote multiple sclerosis treatments in Japan
Based on the agreement two companies will jointly conduct promotional activities at the clinical facilities
Novartis appoints Elizabeth Barrett as oncology head
Barrett currently is Global President Oncology at Pfizer